FDA
-
-
-
-
-
-
-
Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes
-
-
324,864 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

